Next-Generation Sequencing (NGS) Market Insights and Predictions for 2025-2032 | Intensive Research and Development Investments Fuel Market Growth, Reduced Sequencing Costs Improve Accessibility and Adoption – Report by ResearchAndMarkets.com
Growth Projections for the Clinical Next Generation Sequencing (NGS) Market
The clinical Next Generation Sequencing (NGS) market is poised for significant growth over the next decade, with various sources predicting a surge in market size and compound annual growth rates (CAGR).
According to several reports available for purchase on ResearchAndMarkets.com, the global clinical NGS market was valued at USD 6.2 billion in 2024. One source forecasts the market size to grow from approximately US$ 8.42 billion in 2025 to US$ 33.3 billion by 2032, exhibiting a CAGR of 21.7% during 2025–2032. For the clinical segment specifically, another source projects the market reaching US$ 15.2 billion by 2032, with a CAGR of 13.6% over the same period. A third source indicates the NGS market size growing from USD 10.44 billion in 2025 to USD 27.55 billion by 2032, at a CAGR of 14.9%.
The growth of the clinical NGS market is primarily driven by the increasing demand for personalized medicine, falling sequencing costs, and strong R&D investments. Significant investments in research and development are stimulating growth in the global clinical NGS market.
Market Segmentation and Key Players
The market is segmented by application into Genetics, Oncology, Infectious Diseases, Reproductive Health, and Others. Additionally, the market is segmented by product type into Instruments, Workflow Solutions, Informatics, and Services. In terms of region, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and Rest of World (RoW).
Key players in the global clinical NGS market include Roche, Qiagen, Illumina Inc., BGI Genomics, Sophia Genetics, and Thermo Fisher Scientific Inc., among others. The report provides a detailed analysis of these companies, including their competitive landscape, growth drivers, and challenges.
Report Details and Contact Information
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. The report provides a detailed analysis of the global clinical next generation sequencing (NGS) market dynamics, opportunities, future roadmap, competitive landscape, and major trends. It offers up-to-date historical market size data for the period 2023-2024 and an illustrative forecast to 2032.
For more information about the report, contact Laura Wood, Senior Press Manager at [email protected], or refer to the various phone numbers provided for different time zones.
In summary, the clinical NGS market is expected to expand from roughly $8–10 billion in 2025 to between $15 billion and $33 billion by 2032, with CAGRs ranging approximately from 13.6% to 21.7%. The growth is driven by greater adoption of personalized medicine, decreasing costs of sequencing technologies, and increased genomics research and applications in healthcare.
Read also:
- Innovative Garments and Accessories Producing Energy: Exploring Unconventional Sources for Renewable Power
- MoneyGram's Investment in 'Drive to Survive' Yielded Results?
- Stratospheric Blockchain Network Debut by World Mobile and Protelindo
- Embracing the Digital Supply Chain: The Internet of Things (IoT) Arrives
%20Market%20Insights%20and%20Predictions%20for%202025-2032%20%7C%20Intensive%20Research%20and%20Development%20Investments%20Fuel%20Market%20Growth%2C%20Reduced%20Sequencing%20Costs%20Improve%20Accessibility%20and%20Adoption%20%E2%80%93%20Report%20by%20ResearchAndMarkets.com){kind=link}